Published in Immunotherapy Weekly, October 29th, 2008
In most MS patients, the disease primarily affects the spinal cord and the white matter of the brain. But a small percentage of patients develop...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly